Pegasys and hepatitis c

Common Questions and Answers about Pegasys and hepatitis c

pegasys

Avatar m tn I was wondering if there have been any studies comparing Pegasys and Pegintron, and if one has better SVR numbers than the other or was more tolerable. I am new here so I hope I am posting this in the correct forum.
Avatar m tn Hello my name is Tyler i am 22 years old I been a heroin addict since 2006, I dropped out of high school due to my sickness, and lost pretty much everything, even my family, in 2010 I got arrested with 4 ounces of heroin and was charged with a a1 felony b felony c felony and a d felony, I was on rikers island jail for 6 months until I pled guilty to a b felony and got released to a drug program called Phoenix house, here I found out I have chronic hepatitis c, I been seeing a doctor in Nassau co
476246 tn?1418870914 26June2008 Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.
Avatar m tn The 16-week course will be available for patients with genotype 2 or 3 strains of chronic hepatitis C who have low virus levels before starting treatment and show rapid virological response, the Basel-based drug maker said. The altered course of treatments is part of Roche's new response-guided therapy, which seeks to customise regimens based on how well patients respond to therapy.
154668 tn?1290115995 R7128 has shown potent in vivo activity against all of the most common HCV genotypes (1, 2 and 3). R7128 was safe and well-tolerated when given with PEGASYS and COPEGUS for up to 28 days. About PEGASYS PEGASYS, in combination with COPEGUS (ribavirin), is indicated for the treatment of adults with chronic HCV who have compensated liver disease and have not previously been treated with interferon alpha.
694630 tn?1227710675 today announced that Albuferon(R) (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 2/3, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotypes 2 and 3 chronic hepatitis C (p=0.0086). Albinterferon alfa-2b is being developed by HGS and Novartis under an exclusive worldwide co-development and commercialization agreement entered into in June 2006.
Avatar f tn You need more then pegasys to treat Hepatitis C. Present treatment requirers 3 drugs. Interferon, Ribavirin, & Incivik or Victrelis. In order to get any of these drugs you will have to see a GI doctor, Hepatologist if possible. The doctor will run tests to find out what genotype you are, etc.
Avatar n tn As Advocate and Dee mentioned, there is more to the Hepatitis C treatment than just Pegasys. And as Dee mentioned, if you could tell us more about yourself, your Genotype and liver biopsy fibrosis stage, and if you have ever treated before, we may be able to better respond to your questions.
Avatar n tn //www.merck-cares.com/cares/merck-cares/consumer/hepatitis-c-treatment-cost.
Avatar m tn The ONLY proven treatment for Hepatitis C is currently the chemotherapy combination of Interferon and Ribavirin. Brand names are Pegasys, Copegus and Infergen - there are others, I believe - but you'll have to find them.
906884 tn?1242463036 It may be time to ask your doctor to send you to a specialist, either a hepatologist or gastroenterologist or infectious disease doctor and get evaluated. There is treatment for hepatitis C that can cure the disease in 45-80% of people depending on their genotype. I bet your mom will understand.
Avatar f tn MRK), known as MSD outside of the United States and Canada, reported that final results from a Phase III study of VICTRELIS™ (boceprevir), its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a (Pegasys®) and ribavirin therapy demonstrated significantly higher sustained virologic response (SVR)1 rates in adult patients who failed previous treatment for chronic hepatitis C virus (HCV) genotype 1 compared to a control group receiving peginterferon alfa-2a and riba
6708370 tn?1471490210 Sovaldi is a vexing problem for prisons. One-third of the 2.2 million people in jails and prisons in the U.S. have hepatitis C, according to the Centers for Disease Control and Prevention. The Federal Bureau of Prisons gets a discount on Sovaldi and another hepatitis C drug, Olysio. But state prisons generally don't receive the same discounts. Although California's prison system has yet to prescribe Sovaldi, a spokeswoman said the state is seeking approval.
Avatar n tn partner is starting pegasys treatment and i am pregnant. he told me he is starting this due to liver damage because of chemo for testiclur cancer before we met. he has not mentioned hep c to me once. can this treatment be used for other liver damage. thanks.
1321487 tn?1385294679 //www.medhelp.org/posts/Hepatitis-C/Long-term-effects-of-Pegasys-Ribavirin/show/1134324 http://www.medhelp.org/posts/Hepatitis-C/Long-term-after-effects-of-tx-w-Pegasys-or-PegIntron/show/96929 http://www.medhelp.org/posts/Hepatitis-C/5-years-after-Pegasys-interferon-ribavirin-treatment/show/623653 http://www.medhelp.
Avatar m tn A 600 mg/day UDCA dose was optimal to decrease ALT and AST levels in chronic hepatitis C patients. The 900 mg/day dose decreased GGT levels further, and may be preferable in patients with prevailing biliary injuries.
Avatar f tn On-Treatment Management of Hepatitis C Patients. Free registration. Starts on slide #24.